| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594459 | American Heart Journal | 2017 | 29 Pages |
Abstract
The HI-TECH study is the first randomized, crossover study aiming to ascertain whether ticagrelor, when administered at approved regimen in post-ACS patients, improves endothelial function as compared with both clopidogrel and prasugrel.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sara MD, Maarten MD, PhD, Salvatore MD, PhD, Sergio MD, PhD, Kristiaan Martijn MD, PhD, Emrush MD, PhD, Gladys MD, Luis MD, Diego MSc, Jan C. MD, Dierik PhD, Gloria CLS, Stephan MD, Marco MD, PhD, The HI-TECH Investigators The HI-TECH Investigators,